Cardinal Health has good read through from AmerisourceBergen, says Sterne Agee Sterne Agee believes that AmericansourceBergen's (ABC) beat and raise results bode well for Cardinal Health (CAH). The firm keeps a Buy rating on Cardinal.
AmerisourceBergen price target raised to $104 from $83 at Argus Argus increased its price target on AmerisourceBergen after the company reported stronger than expected Q4 results. The firm is confident in the company's ability to improve its profitability while sustaining its organic top-line growth in fiscal 2015. Argus keeps a Buy rating on the shares.